VoltaGrid Closes $5.0 Billion Comprehensive Financing Package Consisting of $2.0 Billion of Senior Secured Second Lien Notes and $3.0 Billion Asset-Based Loan Facility 10-11-2025, 20:00

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer 13-11-2024, 22:57

Philips Foundation 2022 Annual Report: partnering to provide healthcare access to over 26 million people in underserved communities 15-05-2023, 21:00